We are live on ! Find out more
CGA

Crescent Grove Advisors Portfolio holdings

AUM $1.04B
1-Year Est. Return 17.78%
This Fund
S&P 500
This Quarter Est. Return
+6.85%
1 Year Est. Return
+17.78%
3 Year Est. Return
+51.16%
5 Year Est. Return
+28.04%
10 Year Est. Return
AUM
$531M
AUM Growth
+$43M
Cap. Flow
+$12.5M
Cap. Flow %
2.36%
Top 10 Hldgs %
62.35%
Holding
166
New
12
Increased
53
Reduced
47
Closed
6

Sector Composition

Rank Sector Weight
1 Technology 44.35%
2 Industrials 9.87%
3 Financials 5.01%
4 Consumer Discretionary 4.57%
5 Healthcare 1.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBIN icon
151
Merchants Bancorp
MBIN
$2.19B
$171K 0.03%
+15,000
New +$206K
DYSL
152
DELISTED
Dynasil Corporation of America
DYSL
$113K 0.02%
113,465
FIT
153
DELISTED
Fitbit, Inc. Class A common stock
FIT
$110K 0.02%
25,000
PFX icon
154
PhenixFIN
PFX
$93K 0.02%
1,989
PETX
155
DELISTED
Aratana Therapeutics, Inc.
PETX
$93K 0.02%
17,975
SSI
156
DELISTED
Stage Stores Inc
SSI
$73K 0.01%
94,400
LKSD
157
DELISTED
LSC Communications, Inc.
LKSD
$70K 0.01%
+19,000
New +$112K
LL
158
CALL
DELISTED
LL Flooring Holdings, Inc.
LL
$38K 0.01%
50,000
VERU icon
159
Veru
VERU
$36.1M
$32K 0.01%
1,500
UAVS icon
160
AgEagle Aerial Systems
UAVS
$41.4M
$3K ﹤0.01%
10
CMI icon
161
Cummins
CMI
$91.7B
-3,600
Closed -$568K
DXJ icon
162
WisdomTree Japan Hedged Equity Fund
DXJ
$7.23B
-4,041
Closed -$205K
FDUS icon
163
Fidus Investment
FDUS
$737M
-11,277
Closed -$173K
CYTO
164
DELISTED
Altamira Therapeutics Ltd
CYTO
-3
Closed -$7K
SGYP
165
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
-11,200
Closed
ESNC
166
DELISTED
EnSync Inc
ESNC
-20,000
Closed

Similar funds

Crescent Grove Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Crescent Grove Advisors held 166 positions worth $531M, up 8.8% from $488M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Crescent Grove Advisors's Q2 2019 filing shows 12 new, 53 increased, 47 reduced and 6 closed positions. Its largest new stake was QVC Group Inc Series A: 1,735 shares worth $1.04M. The largest sale was Fidelity National Information Services, an estimated $7.77M.

By sector, the portfolio is most concentrated in Technology at 44% of assets, down from 45% a quarter earlier, followed by Industrials and Financials.

  • Crescent Grove Advisors's largest Q2 2019 buy was QVC Group Inc Series A: 1,735 shares worth $1.04M.
  • Crescent Grove Advisors added most to Zurn Elkay Water Solutions in Q2 2019, an estimated $6.94M increase.
  • Crescent Grove Advisors's biggest Q2 2019 reduction was Fidelity National Information Services, cutting an estimated $7.77M.
  • Crescent Grove Advisors fully exited Cummins in Q2 2019, selling an estimated $568K.
  • Crescent Grove Advisors's ten largest holdings make up 62% of its $531M portfolio in Q2 2019.
  • Crescent Grove Advisors opened 12 new positions and closed 6 in Q2 2019.
  • Crescent Grove Advisors's portfolio value rose 8.8% quarter-over-quarter to $531M.

Based on Crescent Grove Advisors's 13F filing for Q2 2019, filed 6 Aug 2019.